Effects of glucose dialysate on extracellular matrix production by human peritoneal mesothelial cells (HPMC): The role of TGF-β

Nephrology Dialysis Transplantation

Volumn 16, Issue 9, 2001, Pages 1885-1892

  Medcalf, James F ^a   Walls, John ^a   Pawluczyk, Izabella Z A ^a   Harris, Kevin P G ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

CAPD; Dialysis solutions; Extracellular matrix proteins; Glucose; Mesothelial cells; TGF

Indexed keywords

DIALYSIS FLUID; FIBRONECTIN; GLUCOSE; LACTATE DEHYDROGENASE; MESSENGER RNA; PD 4; PROTEIN ANTIBODY; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CELL STIMULATION; CELL VIABILITY; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIALYSATE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; EXTRACELLULAR MATRIX; FIBROSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LONG TERM CARE; MESOTHELIUM CELL; NORTHERN BLOTTING; OSMOLALITY; PERITONEUM; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 0034839087     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.9.1885     Document Type: Article

References (26)

1. A multi-center selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis
2. Comparison of survival in continuous ambulatory peritoneal dialysis: A multicentre study
3. Outcome in patients on continuous ambulatory peritoneal dialysis and haemodialysis: 4-year analysis of prospective multicentre study
4. Issues affecting the longevity of the continuous peritoneal dialysis therapy
5. Acute and long-term changes observed in imprints of mouse mesothelium exposed to glucose-enriched, lactated, buffered dialysis solutions
6. Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis
7. Peritoneal morphology on maintenance dialysis
8. Biocompatibility of peritoneal dialysis fluids
9. Biocompatibility studies on peritoneal cells
10. Effects of osmotic solutes on fibronectin mRNA expression in rat peritoneal mesothelial cells
11. Effects of high concentration glucose on cell growth and matrix biosynthesis in human peritoneal mesothelial cells
12. Effect of glucose on TGF-beta 1 expression in peritoneal mesothelial cells
13. PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products
14. The family of matrix metalloproteinases
15. Isolation, culture and characterisation of human peritoneal mesothelial cells
16. Human peritoneal mesothelial cell prostaglandin synthesis: Induction of cyclo-oxygenase mRNA by peritoneal macrophage-derived cytokines
17. Fibronectin production by human tubular cells: The effect of apical protein
18. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
19. Peritoneal equilibration test
20. Expression of genes related to the extracellular matrix in human endothelial cells. Differential modulation by elevated glucose concentrations, phorbol esters and cAMP
21. Exposure of human renal proximal tubular cells to glucose leads to accumulation of type IV collagen and fibronectin by decreased degradation
22. Hyperosmolality suppresses but TGF-beta 1 increases MMP9 in human peritoneal mesothelial cells
23. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: Transcriptional regulation by TGF-beta1
24. Production and regulation of metalloproteinases (MMPs) and their inhibitors (TIMPs) by human peritoneal mesothelial cells (HPMC)
25. Improved cell function in pyruvate-buffered peritoneal dialysis fluids is related to specific antagonism of the polyol pathway
26. High glucose-induced transforming growth factor beta 1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells